Books > Medicine > Clinical & internal medicine > Neurology & clinical neurophysiology
|
Buy Now
Profiles of Drug Substances, Excipients, and Related Methodology, Volume 42 (Hardcover)
Loot Price: R5,197
Discovery Miles 51 970
|
|
Profiles of Drug Substances, Excipients, and Related Methodology, Volume 42 (Hardcover)
Series: Profiles of Drug Substances, Excipients and Related Methodology
Expected to ship within 12 - 17 working days
|
Profiles of Drug Substances, Excipients, and Related Methodology,
Volume 42 presents comprehensive reviews of drug substances and
additional materials, with critical review chapters that summarize
information related to the characterization of drug substances and
excipients, thus meeting the needs of the pharmaceutical community
and allowing for the development of a timely vehicle for publishing
review materials on the topic. This latest release covers a variety
of substances, including Cinacalcet Hydrochloride, Clenbuterol
Hydrochloride, Gliclazide, Lomefloxacin, Olmesartan, Propranolol,
and Tolterodine Tartrate. The scope of the Profiles series
encompasses review articles and database compilations that fall
within one of the following six broad categories, Physical profiles
of drug substances and excipients, Analytical profiles of drug
substances and excipients, Drug metabolism and pharmacokinetic
profiles of drug substances and excipients, Methodology related to
the characterization of drug substances and excipients, Methods of
chemical synthesis, and Reviews of the uses and applications for
individual drug substances, classes of drug substances, or
excipients.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.